Psychometric properties of the Activities Scale for Kids-performance after allogeneic hematopoietic stem cell transplantation in adolescents and children : Results of a prospective study on behalf of the German-Austrian-Swiss GVHD Consortium
- PMID: 32246210
- PMCID: PMC7840624
- DOI: 10.1007/s00508-020-01641-w
Psychometric properties of the Activities Scale for Kids-performance after allogeneic hematopoietic stem cell transplantation in adolescents and children : Results of a prospective study on behalf of the German-Austrian-Swiss GVHD Consortium
Erratum in
-
Correction to: Psychometric properties of the Activities Scale for Kids-performance after allogeneic hematopoietic stem cell transplantation in adolescents and children : Results of a prospective study on behalf of the German-Austrian-Swiss GVHD consortium.Wien Klin Wochenschr. 2021 Jul;133(13-14):729-730. doi: 10.1007/s00508-021-01902-2. Wien Klin Wochenschr. 2021. PMID: 34196804 Free PMC article. No abstract available.
Abstract
Background: The psychometric properties of an instrument, the Activity Scale for Kids-performance (ASKp), were assessed which was proposed to capture physical functioning after allogeneic hematopoietic stem cell transplantation (HSCT). Additionally, this multicenter observational prospective study investigated the influence of clinical correlates focusing on chronic graft-versus-host disease (cGVHD).
Methods: Patient-reported ASKp, clinician-reported Karnofsky/Lansky status (KPS/PSS), patient characteristics and cGVHD details were assessed of 55 patients with a median age of 12 years at baseline after day +100 post-HSCT and every 3 months during the next 18 months. The psychometric properties were evaluated and ASKp and KPS/PSS status was compared using ANOVAS and multiple regression models.
Results: The German version of the ASKp showed good psychometric properties except for ceiling effects. Discrimination ability of the ASKp was good regarding the need for devices but failed to predict cGVHD patients. Both the ASKp and the KPS/PSS were associated with patients after adoptive cell therapy being in need for devices, suffering from overlap cGVHD and from steroid side effects but not with patients' age and gender. In contrast to the KPS/PSS the ASKp only showed significant differences after merging moderate and severe cGHVD patients when comparing them to No-cGVHD (F = 4.050; p = 0.049), being outperformed by the KPS/PSS (F = 20.082; p < 0.001).
Conclusion: The ASKp showed no clear advantages compared to KPS/PSS even though economical and patients' effort was higher. Further application range may be limited through ceiling effects. Both should be taken into consideration. Therefore, the results may not support the usage of ASKp after HSCT and rather suggest KPS/PSS, both patient and clinician reported.
Keywords: AYAs; Cancer patients; GVHD; Physical functioning.
Conflict of interest statement
A. Lawitschka, M. Brunmair, D. Bauer, N. Zubarovskaya, R. Felder-Puig, B. Strahm, P. Bader, G. Strauss, M. Albert, I.von Luettichau, H. Greinix, D. Wolff, and C. Peters declare that they have no competing interests.
Figures



Similar articles
-
Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant. 2010 Dec;16(12):1707-17. doi: 10.1016/j.bbmt.2010.05.018. Epub 2010 Jun 9. Biol Blood Marrow Transplant. 2010. PMID: 20541028
-
Diagnosis and staging of chronic graft-versus-host disease in the clinical practice.Biol Blood Marrow Transplant. 2011 Feb;17(2):167-75. doi: 10.1016/j.bbmt.2010.07.017. Epub 2010 Aug 5. Biol Blood Marrow Transplant. 2011. PMID: 20691801
-
Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD.Cornea. 2012 Mar;31(3):299-310. doi: 10.1097/ICO.0b013e318226bf97. Cornea. 2012. PMID: 22157574
-
Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland.Biol Blood Marrow Transplant. 2019 Jul;25(7):1450-1455. doi: 10.1016/j.bbmt.2019.03.003. Epub 2019 Mar 13. Biol Blood Marrow Transplant. 2019. PMID: 30876928
-
German-Austrian-Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD.Br J Dermatol. 2011 Jul;165(1):18-29. doi: 10.1111/j.1365-2133.2011.10360.x. Epub 2011 May 26. Br J Dermatol. 2011. PMID: 21466534
Cited by
-
Psychometric properties of the Spanish version of the Activities Scale for Kids (ASK): reliability, validity and the Rasch model.BMJ Open. 2023 Apr 27;13(4):e069248. doi: 10.1136/bmjopen-2022-069248. BMJ Open. 2023. PMID: 37105695 Free PMC article.
References
-
- Duell T, et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med. 1997;126(3):184–192. doi: 10.7326/0003-4819-126-3-199702010-00002. - DOI - PubMed
-
- Parsons SK, Phipps S, Sung L, Baker KS, Pulsipher MA, Ness KK. NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: health-related quality of life, functional, and neurocognitive outcomes. Biol Blood Marrow Transplant. 2012;18(2):162–171. doi: 10.1016/j.bbmt.2011.12.501. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources